3331

antibody from Cell Signaling Technology, Inc

Targeting: JAK1 JAK1A, JAK1B, JTK3

Western blot (Data presented on provider website)

Antibody Data

Product number

3331

Provider

Cell Signaling Technology, Inc

Proper citation

Cell Signaling Technology Cat#3331, RRID:AB_2265057

Product name

Phospho-Jak1 (Tyr1034/1035) Antibody

Antibody type

Polyclonal

Reactivity

Human, Mouse

Host

Rabbit

Storage

-20°C

References

Submitted references

CUEDC2 (CUE domain-containing 2) and SOCS3 (suppressors of cytokine signaling 3) cooperate to negatively regulate Janus kinase 1/signal transducers and activators of transcription 3 signaling.

Zhang WN, Wang L, Wang Q, Luo X, Fang DF, Chen Y, Pan X, Man JH, Xia Q, Jin BF, Li WH, Li T, Liang B, Chen L, Gong WL, Yu M, Li AL, Zhou T, Li HY
The Journal of biological chemistry 2012 Jan 2;287(1):382-92

---

Hepatocyte growth factor suppresses the anticancer effect of irinotecan by decreasing the level of active metabolite in HepG2 cells.

Okumura M, Iwakiri T, Takagi A, Hirabara Y, Kawano Y, Arimori K
Biochemical pharmacology 2011 Dec 1;82(11):1720-30

---

SD-1029 inhibits signal transducer and activator of transcription 3 nuclear translocation.

Duan Z, Bradner JE, Greenberg E, Levine R, Foster R, Mahoney J, Seiden MV
Clinical cancer research : an official journal of the American Association for Cancer Research 2006 Nov 15;12(22):6844-52